CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C34104 | BRD-M29370314 | BRD-M29370314 | -- | -- | -- | Details |
| C34105 | BRD-M30251550 | penbutolol | ADRB2 | Adrenergic receptor antagonist | -- | Details |
| C34106 | BRD-M30523314 | vinorelbine | TUBB | Tubulin inhibitor | -- | Details |
| C34107 | BRD-M30664582 | BRD-M30664582 | -- | -- | -- | Details |
| C34108 | BRD-M30758753 | BRD-M30758753 | -- | -- | -- | Details |
| C34109 | BRD-M31016039 | BRD-M31016039 | -- | -- | -- | Details |
| C34110 | BRD-M31111440 | BRD-M31111440 | -- | -- | -- | Details |
| C34111 | BRD-M31871110 | BRD-M31871110 | -- | -- | -- | Details |
| C34112 | BRD-M32495507 | BRD-M32495507 | -- | -- | -- | Details |
| C34113 | BRD-M32778103 | BRD-M32778103 | -- | -- | -- | Details |
| C34114 | BRD-M33077182 | BRD-M33077182 | -- | -- | -- | Details |
| C34115 | BRD-M34385771 | BRD-M34385771 | -- | -- | -- | Details |
| C34116 | BRD-M34926192 | guanadrel | SLC6A2 | Adrenergic inhibitor | -- | Details |
| C34117 | BRD-M35773784 | atropine | CHRM1; CHRM2; CHRM3; CHRM4; CHRM5 | Acetylcholine receptor antagonist | -- | Details |
| C34118 | BRD-M36167927 | BRD-M36167927 | -- | -- | -- | Details |
| C34119 | BRD-M37402942 | benzathine | -- | -- | -- | Details |
| C34120 | BRD-M39350793 | reboxetine | SLC6A2 | Adrenergic receptor antagonist | -- | Details |
| C34121 | BRD-M39727370 | BRD-M39727370 | -- | -- | -- | Details |
| C34122 | BRD-M39787390 | BRD-M39787390 | -- | -- | -- | Details |
| C34123 | BRD-M39894156 | BRD-M39894156 | -- | -- | -- | Details |
| C34124 | BRD-M39942365 | xamoterol | ADRB1 | Adrenergic receptor agonist | -- | Details |
| C34125 | BRD-M40384033 | BRD-M40384033 | -- | -- | -- | Details |
| C34126 | BRD-M40773246 | BRD-M40773246 | -- | -- | -- | Details |
| C34127 | BRD-M40783228 | mesna | -- | -- | -- | Details |
| C34128 | BRD-M41106164 | oxantel | -- | -- | -- | Details |
| C34129 | BRD-M41154708 | BRD-M41154708 | -- | -- | -- | Details |
| C34130 | BRD-M41610223 | BRD-M41610223 | -- | -- | -- | Details |
| C34131 | BRD-M41783010 | acamprosate | -- | -- | -- | Details |
| C34132 | BRD-M43082489 | BRD-M43082489 | -- | -- | -- | Details |
| C34133 | BRD-M43490210 | oxaliplatin | -- | -- | -- | Details |
| C34134 | BRD-M44900776 | BRD-M44900776 | -- | -- | -- | Details |
| C34135 | BRD-M45038741 | metoprolol | ADRB1; ADRB2 | Adrenergic receptor antagonist | -- | Details |
| C34136 | BRD-M45350951 | BRD-M45350951 | -- | -- | -- | Details |
| C34137 | BRD-M45544666 | BRD-M45544666 | -- | -- | -- | Details |
| C34138 | BRD-M45580279 | mebhydrolin | -- | -- | -- | Details |
| C34139 | BRD-M45659198 | OVE-238 | -- | -- | -- | Details |
| C34140 | BRD-M45755366 | BRD-M45755366 | -- | -- | -- | Details |
| C34141 | BRD-M45964048 | verteporfin | -- | -- | -- | Details |
| C34142 | BRD-M46651441 | BRD-M46651441 | -- | -- | -- | Details |
| C34143 | BRD-M47397275 | BRD-M47397275 | -- | -- | -- | Details |
| C34144 | BRD-M47793593 | picrotoxin | GABRA1; GABRR1; GLRA2; GLRA3 | GABA receptor antagonist | -- | Details |
| C34145 | BRD-M47937986 | cefatrizine | -- | -- | -- | Details |
| C34146 | BRD-M49151292 | BRD-M49151292 | -- | -- | -- | Details |
| C34147 | BRD-M51208417 | BRD-M51208417 | -- | -- | -- | Details |
| C34148 | BRD-M51239075 | BRD-M51239075 | -- | -- | -- | Details |
| C34149 | BRD-M52804417 | BRD-M52804417 | -- | -- | -- | Details |
| C34150 | BRD-M53001068 | aminophylline | ADORA1; ADORA2A; ADORA2B; ADORA3; PDE3A | Adenosine receptor antagonist | -- | Details |
| C34151 | BRD-M53302603 | BRD-M53302603 | -- | -- | -- | Details |
| C34152 | BRD-M53346459 | BRD-M53346459 | -- | -- | -- | Details |
| C34153 | BRD-M54407015 | BRD-M54407015 | -- | -- | -- | Details |
| C34154 | BRD-M54814689 | BRD-M54814689 | -- | -- | -- | Details |
| C34155 | BRD-M55020616 | BRD-M55020616 | -- | -- | -- | Details |
| C34156 | BRD-M56188090 | BRD-M56188090 | -- | -- | -- | Details |
| C34157 | BRD-M56587789 | ibutilide | KCNH2; CACNA1C | Potassium channel blocker | -- | Details |
| C34158 | BRD-M57185017 | BRD-M57185017 | -- | -- | U-50488-(+/-) | Details |
| C34159 | BRD-M57433836 | BRD-M57433836 | -- | -- | -- | Details |
| C34160 | BRD-M58317392 | BRD-M58317392 | -- | -- | -- | Details |
| C34161 | BRD-M58473998 | alimemazine | HRH1 | Histamine receptor ligand; Histamine receptor agonist | -- | Details |
| C34162 | BRD-M58692868 | BRD-M58692868 | -- | -- | -- | Details |
| C34163 | BRD-M59180619 | BRD-M59180619 | -- | -- | -- | Details |
| C34164 | BRD-M59406954 | BRD-M59406954 | -- | -- | -- | Details |
| C34165 | BRD-M59543297 | isometheptene | -- | -- | -- | Details |
| C34166 | BRD-M60886831 | BRD-M60886831 | -- | -- | -- | Details |
| C34167 | BRD-M61246020 | fenoprofen | PTGS1 | Prostagladin inhibitor | -- | Details |
| C34168 | BRD-M61872305 | mephentermine | -- | -- | -- | Details |
| C34169 | BRD-M62162320 | rilmenidine | NISCH; ADRA2A | Adrenergic receptor agonist; Imidazoline receptor agonist | -- | Details |
| C34170 | BRD-M62752003 | BRD-M62752003 | -- | -- | -- | Details |
| C34171 | BRD-M63173034 | clonixin-lysinate | -- | -- | -- | Details |
| C34172 | BRD-M63389385 | BRD-M63389385 | -- | -- | -- | Details |
| C34173 | BRD-M64432851 | sunitinib | FLT1; FLT3; FLT4; KDR; KIT; PDGFRA; PDGFRB; RET | KIT inhibitor; FLT3 inhibitor; PDGFR inhibitor; VEGFR inhibitor; RET tyrosine kinase inhibitor | -- | Details |
| C34174 | BRD-M64817521 | BRD-M64817521 | -- | -- | -- | Details |
| C34175 | BRD-M65187017 | BRD-M65187017 | -- | -- | -- | Details |
| C34176 | BRD-M66254575 | BRD-M66254575 | -- | -- | -- | Details |
| C34177 | BRD-M66672790 | BRD-M66672790 | -- | -- | -- | Details |
| C34178 | BRD-M66781690 | OVE-208 | -- | -- | -- | Details |
| C34179 | BRD-M66874015 | quetiapine | DRD1; DRD2; HRH1; HTR1A; HTR1D; HTR1E; HTR2A | Dopamine receptor antagonist; Serotonin receptor antagonist | quetiapine-fumarate | Details |
| C34180 | BRD-M67215567 | BRD-M67215567 | -- | -- | -- | Details |
| C34181 | BRD-M68558198 | BRD-M68558198 | -- | -- | -- | Details |
| C34182 | BRD-M69191681 | BRD-M69191681 | -- | -- | -- | Details |
| C34183 | BRD-M69929484 | BRD-M69929484 | -- | -- | -- | Details |
| C34184 | BRD-M70861773 | BRD-M70861773 | -- | -- | -- | Details |
| C34185 | BRD-M72045552 | BRD-M72045552 | -- | -- | -- | Details |
| C34186 | BRD-M72442222 | vicriviroc | CCR5 | CCK receptor antagonist | -- | Details |
| C34187 | BRD-M72639231 | BRD-M72639231 | -- | -- | -- | Details |
| C34188 | BRD-M72681210 | eserine | -- | -- | -- | Details |
| C34189 | BRD-M72906282 | BRD-M72906282 | -- | -- | -- | Details |
| C34190 | BRD-M73371355 | apomorphine | ADRA2A; ADRA2B; ADRA2C; DRD1; DRD2; DRD3; DRD4; DRD5; HTR1A; HTR2A; HTR2B; HTR2C; TRPA1 | Dopamine receptor agonist | -- | Details |
| C34191 | BRD-M73564418 | BRD-M73564418 | -- | -- | -- | Details |
| C34192 | BRD-M74254599 | lithium-chloride | -- | -- | -- | Details |
| C34193 | BRD-M74304337 | BRD-M74304337 | -- | -- | -- | Details |
| C34194 | BRD-M76499661 | BRD-M76499661 | -- | -- | -- | Details |
| C34195 | BRD-M76969896 | BRD-M76969896 | -- | -- | -- | Details |
| C34196 | BRD-M77258496 | BRD-M77258496 | -- | -- | -- | Details |
| C34197 | BRD-M77293869 | BRD-M77293869 | -- | -- | -- | Details |
| C34198 | BRD-M77861050 | BRD-M77861050 | -- | -- | -- | Details |
| C34199 | BRD-M78319284 | BRD-M78319284 | -- | -- | -- | Details |
| C34200 | BRD-M78942891 | BRD-M78942891 | -- | -- | -- | Details |
| C34201 | BRD-M79326715 | BRD-M79326715 | -- | -- | -- | Details |
| C34202 | BRD-M79902621 | terbutaline | ADRB2 | Adrenergic receptor agonist | -- | Details |
| C34203 | BRD-M80207679 | nemonapride | DRD2; DRD3 | Dopamine receptor antagonist | -- | Details |